« back to directory
About Vaxine Pty Ltd
Vaxine was founded in 2002 as a spin out of the National Health Sciences Centre (NHSC) in Canberra to develop novel vaccine technologies. Vaxine is situated within the Flinders University precinct in Adelaide providing Vaxine with ideal opportunities for bench to bedside vaccine research and development. Vaxine’s lead product is Advax™, a novel sugar-based technology that enhances vaccine effectiveness. Advax™ has already proved successful in late-stage human trials in vaccines against hepatitis B, pandemic influenza and allergy.